{
    "title": "Aclaris shares tank as skin disorder drug fails mid-stage study",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11825993/Aclaris-drug-fails-treat-skin-disorder-mid-stage-study.html",
    "date": "2023-03-06",
    "keywords": [
        "drug",
        "hs",
        "goal",
        "study",
        "skin",
        "arthritis",
        "march",
        "monday",
        "midstage",
        "disorder",
        "premarket",
        "trading",
        "zunsemetinib",
        "hidradenitis",
        "suppurativa",
        "week",
        "placebo",
        "inflammatory",
        "condition",
        "percentage",
        "reduction",
        "number",
        "aclaris",
        "population",
        "phosphokinase",
        "rival",
        "analyst",
        "alex",
        "thompson",
        "note",
        "investor",
        "debate",
        "safety",
        "bell",
        "reporting",
        "raghav",
        "mahobe",
        "bengaluru",
        "editing",
        "anil",
        "dsilva"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}